These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11890253)

  • 41. Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma.
    Lang SH; Hyde C; Reid IN; Hitchcock IS; Hart CA; Bryden AA; Villette JM; Stower MJ; Maitland NJ
    Prostate; 2002 Sep; 52(4):253-63. PubMed ID: 12210485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of skeletal muscle-type voltage-gated Na+ channel in rat and human prostate cancer cell lines.
    Diss JK; Stewart D; Fraser SP; Black JA; Dib-Hajj S; Waxman SG; Archer SN; Djamgoz MB
    FEBS Lett; 1998 May; 427(1):5-10. PubMed ID: 9613589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo antitumor activity of bropirimine against PAIII and Dunning MAT-LyLu rodent prostate cancers.
    Sarosdy MF; Higdon AL; Demoor CA
    J Urol; 1996 Jun; 155(6):2085-9. PubMed ID: 8618341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation.
    Fraser SP; Grimes JA; Diss JK; Stewart D; Dolly JO; Djamgoz MB
    Pflugers Arch; 2003 Aug; 446(5):559-71. PubMed ID: 12838421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contact-mediated acceleration of migration of melanoma B16 cells depends on extracellular calcium ions.
    Madeja Z; Master A; Michalik M; Sroka J
    Folia Biol (Krakow); 2001; 49(3-4):113-24. PubMed ID: 11987446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of gossypol on the invasiveness of MAT-LyLu cells and MAT-LyLu cells from the metastasized lungs of MAT-LyLu-bearing Copenhagen rats.
    Jiang J; Kulp SK; Sugimoto Y; Liu S; Lin YC
    Anticancer Res; 2000; 20(6B):4591-7. PubMed ID: 11205308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
    Reyes I; Tiwari R; Geliebter J; Reyes N
    Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. On the biophysics of cathodal galvanotaxis in rat prostate cancer cells: Poisson-Nernst-Planck equation approach.
    Borys P
    Eur Biophys J; 2012 Jun; 41(6):527-34. PubMed ID: 22466868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell surface charge in predicting metastatic potential of aspirated cells from the Dunning rat prostatic adenocarcinoma model.
    Carter HB; Coffey DS
    J Urol; 1988 Jul; 140(1):173-5. PubMed ID: 3379685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Naringenin inhibits prostate cancer metastasis by blocking voltage-gated sodium channels.
    Gumushan Aktas H; Akgun T
    Biomed Pharmacother; 2018 Oct; 106():770-775. PubMed ID: 29990870
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flow cytometric assay of pinocytosis: correlation with membrane ruffling and metastatic potential in the Dunning R-3327 rat prostatic adenocarcinoma model.
    Mohler JL; Sharief Y
    Cytometry; 1993 Oct; 14(7):826-31. PubMed ID: 8243212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mycobacterium vaccae (SRL172): a potential immunological adjuvant evaluated in rat prostate cancer.
    Hrouda D; Souberbielle BE; Kayaga J; Corbishley CM; Kirby RS; Dalgleish AG
    Br J Urol; 1998 Dec; 82(6):870-6. PubMed ID: 9883227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer.
    Garikapaty VP; Ashok BT; Chen YG; Mittelman A; Iatropoulos M; Tiwari RK
    Oncol Rep; 2005 Jan; 13(1):89-93. PubMed ID: 15583807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of hydrazine sulfate on prostate cancer growth.
    Kamradt JM; Pienta KJ
    Oncol Rep; 1998; 5(4):919-21. PubMed ID: 9625846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
    Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
    Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral bropirimine immunotherapy of rodent prostate cancer.
    Sarosdy MF
    Eur Urol; 1997; 31 Suppl 1():5-9. PubMed ID: 9076480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer.
    Naik HR; Lehr JE; Pienta KJ
    Anticancer Res; 1994; 14(6B):2617-9. PubMed ID: 7872690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A study of membrane activity in rat prostate cancer cells: an evaluation of the FM1-43 dye technique.
    Mycielska ME; Schäfer M; Fraser SP; Djamgoz MB; Bashford CL
    Biosci Rep; 2000 Feb; 20(1):31-40. PubMed ID: 10888409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can homeopathic treatment slow prostate cancer growth?
    Jonas WB; Gaddipati JP; Rajeshkumar NV; Sharma A; Thangapazham RL; Warren J; Singh AK; Ives JA; Olsen C; Mog SR; Maheshwari RK
    Integr Cancer Ther; 2006 Dec; 5(4):343-9. PubMed ID: 17101763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.